HK Stock MarketDetailed Quotes

01548 GENSCRIPT BIO

Watchlist

10.960
-0.040-0.36%

Not Open Nov 28 16:08 CST

23.43BMarket Cap-16939P/E (TTM)

GENSCRIPT BIO Stock Forum

Moomoo AI

Mar 13 17:52

Genscript Biotech's high P/S ratio is due to its promising revenue outlook. The company's strong performance and bright future are likely to keep supporting the share price unless conditions change.

Genscript Biotech Corporation's (HKG:1548) P/S Is Still On The Mark Following 29% Share Price Bounce

Moomoo AI

Mar 8 07:06

GenScript's leadership values Dr. Liu's expertise in genome editing, chemistry, and synthetic biology for its potential to offer key insights. His addition to the SAB is anticipated to boost GenScript's platform and hasten transformative breakthroughs for patients.

Press Release: Dr. David Liu Joins GenScript's Scientific Advisory Board to Guide Company's Innovation Strategy

Moomoo AI

Mar 6 09:06

Dr. June joining GenScript's SAB could provide invaluable insights for their initiatives, especially in cell and gene therapy. His expertise may accelerate the development of novel therapies.

Press Release: Immunotherapy Pioneer Carl H. June, MD, Joins GenScript's Scientific Advisory Board to Guide Company's Innovation Strategy in Advancing Cell and Gene Therapy Breakthroughs

Spinee

Jan 17 02:21

HSI Plunge Once Deepens to 620 Pts; Pharmas In Sell-off

$Hang Seng Index (800000.HK)$ plunge deepened unceasingly after midday. It once stumbled 620 pts or 3.9% to bottom at 15,245, hitting an over-14-month low; last at 15,320, down 545 pts or 3.4%, with a total turnover of $88.5 billion.
Pharmaceuticals were sold off. $REMEGEN (09995.HK)$ once collapsed 27.5% to $22.8; last at $24.9, down 21%.
$CLOVER BIO-B (02197.HK)$ nosedived 9.6% to $0.47, hitting record low. $VIVA BIOTECH (01873.HK)$ ...

Moomoo AI

Jan 9 00:19

Despite Genscript Biotech's promising revenue outlook, its P/S ratio isn't higher than industry peers due to potential volatility in revenue forecasts. Investors should note the company's 2 warning signs.

Genscript Biotech Corporation's (HKG:1548) Shares Not Telling The Full Story

Moomoo AI

Dec 13, 2023 17:36

The continuous sell-off of shares by insiders could be concerning for shareholders, as this does not reflect confidence in the company’s outlook. This activity indicates that investors may need to exercise caution when considering investment in Genscript Biotech.

Genscript Biotech Insiders Sell US$10m Of Stock, Possibly Signalling Caution

Moomoo AI

Nov 20, 2023 18:16

Genscript Biotech, though in debt, retains substantial net cash, suggesting manageable debt. Its remarkable revenue surge last year could point to future profitability, but its presently unprofitability at the EBIT level and recent negative cash outflows suggest more capital might be needed. The overall risk for Genscript Biotech is notable at this point.

Is Genscript Biotech (HKG:1548) Using Debt In A Risky Way?

Spinee

Jul 21, 2023 08:16

HKD191.9M Southbound Trading Net Inflow to KUAISHOU-W

There was HKD191.9 million, HKD189.2 million and HKD132.6 million Southbound Trading net inflow to $KUAISHOU-W (01024.HK)$ , $TENCENT (00700.HK)$ and $SENSETIME-W (00020.HK)$ .
There was HKD95.3 million Southbound Trading net outflow from $GENSCRIPT BIO (01548.HK)$ .
For $SH->HK Connect (GangGuTong.HK)$ , $CHINA MOBILE (00941.HK)$ was the most active stock with highest net inflow of HKD205.2 million, while $HUANENG POWER (00902.HK)$ was the m...

Spinee

Apr 25, 2023 11:34

HSI Slides 342 Pts; Techs & Pharmas Gloom

$Hang Seng Index (800000.HK)$ concluded the day at 19,617, down 342 pts or 1.7%. $Hang Seng China Enterprises Index (800100.HK)$ sagged 131 pts or 2% to 6,601. $Hang Seng TECH Index (800700.HK)$ faded 137 pts or 3.5% to 3,824. The turnover aggregated $106.657 billion.
Techs slid as the market continued to be watchful of the Sino-US relations:
$BABA-W (09988.HK)$ dived 3.2% to $84.1.
$TENCENT (00700.HK)$ sank 1.9% to $338.4.
$MEITUAN-W (03690.HK)$ , $XIAOMI-W (01810.HK)$ , ...

BigJoey

Nov 11, 2021 00:47

$GENSCRIPT BIO (01548.HK)$
The development trend of Kingsley company is thriving, and the strength of the short market is like the vehicle on the wrong side of the lane in the rush, its outcome will be faced with a tragic situation, Monday short market to borrow shares, the results of low by Hong Kong shares to do more money to buy 1.31 million shares.

No comment yet

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data